Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302287398> ?p ?o ?g. }
- W4302287398 endingPage "2970" @default.
- W4302287398 startingPage "2958" @default.
- W4302287398 abstract "Low-dose aspirin is currently recommended for patients with polycythemia vera (PV), a myeloproliferative neoplasm with increased risk of arterial and venous thromboses. Based on aspirin pharmacodynamics in essential thrombocythemia, a twice-daily regimen is recommended for patients with PV deemed at particularly high thrombotic risk. We investigated the effects of low-dose aspirin on platelet cyclooxygenase activity and in vivo platelet activation in 49 patients with PV, as assessed by serum thromboxane (TX) B2 and urinary TXA2 /TXB2 metabolite (TXM) measurements, respectively. A previously described pharmacokinetic-pharmacodynamic in silico model was used to simulate the degree of platelet TXA2 inhibition by once-daily (q.d.) and twice-daily (b.i.d.) aspirin, and to predict the effect of missing an aspirin dose during q.d. and b.i.d. regimens. Serum TXB2 averaged 8.2 (1.6-54.7) ng/ml and significantly correlated with the platelet count (γ = 0.39) and urinary TXM (γ = 0.52) in multivariable analysis. One-third of aspirin-treated patients with PV displayed less-than-maximal platelet TXB2 inhibition, and were characterized by significantly higher platelet counts and platelet-count corrected serum TXB2 than those with adequate inhibition. Eight patients with PV were sampled again after 12 ± 4 months, and had reproducible serum TXB2 and urinary TXM values. The in silico model predicted complete inhibition of platelet-derived TXB2 by b.i.d. aspirin, a prediction verified in a patient with PV with the highest TXB2 value while on aspirin q.d. and treated short-term with a b.i.d. regimen. In conclusion, one in three patients with PV on low-dose aspirin display less-than-maximal inhibition of platelet TXA2 production. Serum TXB2 measurement can be a valuable option to guide precision dosing of antiplatelet therapy in patients with PV." @default.
- W4302287398 created "2022-10-06" @default.
- W4302287398 creator A5000667421 @default.
- W4302287398 creator A5004341489 @default.
- W4302287398 creator A5012710359 @default.
- W4302287398 creator A5015829148 @default.
- W4302287398 creator A5019993467 @default.
- W4302287398 creator A5036665064 @default.
- W4302287398 creator A5037962146 @default.
- W4302287398 creator A5052806409 @default.
- W4302287398 creator A5057207523 @default.
- W4302287398 creator A5060595885 @default.
- W4302287398 creator A5070737798 @default.
- W4302287398 date "2022-10-05" @default.
- W4302287398 modified "2023-10-16" @default.
- W4302287398 title "Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation" @default.
- W4302287398 cites W1630039729 @default.
- W4302287398 cites W1884746267 @default.
- W4302287398 cites W1952120822 @default.
- W4302287398 cites W1979832242 @default.
- W4302287398 cites W1980497805 @default.
- W4302287398 cites W1986329429 @default.
- W4302287398 cites W1998630369 @default.
- W4302287398 cites W2000366347 @default.
- W4302287398 cites W2008632318 @default.
- W4302287398 cites W2010075352 @default.
- W4302287398 cites W2011861566 @default.
- W4302287398 cites W2014644245 @default.
- W4302287398 cites W2017299352 @default.
- W4302287398 cites W2018838972 @default.
- W4302287398 cites W2020385939 @default.
- W4302287398 cites W2064888666 @default.
- W4302287398 cites W2065159753 @default.
- W4302287398 cites W2086100979 @default.
- W4302287398 cites W2110316381 @default.
- W4302287398 cites W2112357684 @default.
- W4302287398 cites W2123587611 @default.
- W4302287398 cites W2125389594 @default.
- W4302287398 cites W2147195562 @default.
- W4302287398 cites W2172076271 @default.
- W4302287398 cites W2293189561 @default.
- W4302287398 cites W2323985047 @default.
- W4302287398 cites W2339401565 @default.
- W4302287398 cites W2385547 @default.
- W4302287398 cites W2417384066 @default.
- W4302287398 cites W2478356558 @default.
- W4302287398 cites W2604114528 @default.
- W4302287398 cites W2740659633 @default.
- W4302287398 cites W2783299760 @default.
- W4302287398 cites W2801789113 @default.
- W4302287398 cites W2808449626 @default.
- W4302287398 cites W2895193438 @default.
- W4302287398 cites W2934572398 @default.
- W4302287398 cites W2947677238 @default.
- W4302287398 cites W2982343288 @default.
- W4302287398 cites W3015123096 @default.
- W4302287398 cites W3043324822 @default.
- W4302287398 cites W3088307847 @default.
- W4302287398 cites W3094324484 @default.
- W4302287398 cites W3110612530 @default.
- W4302287398 cites W3123541770 @default.
- W4302287398 cites W3133323869 @default.
- W4302287398 cites W3134099818 @default.
- W4302287398 cites W3146308752 @default.
- W4302287398 cites W3162081154 @default.
- W4302287398 cites W4200603057 @default.
- W4302287398 cites W4229976500 @default.
- W4302287398 cites W4302287398 @default.
- W4302287398 doi "https://doi.org/10.1111/cts.13415" @default.
- W4302287398 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36200184" @default.
- W4302287398 hasPublicationYear "2022" @default.
- W4302287398 type Work @default.
- W4302287398 citedByCount "3" @default.
- W4302287398 countsByYear W43022873982022 @default.
- W4302287398 countsByYear W43022873982023 @default.
- W4302287398 crossrefType "journal-article" @default.
- W4302287398 hasAuthorship W4302287398A5000667421 @default.
- W4302287398 hasAuthorship W4302287398A5004341489 @default.
- W4302287398 hasAuthorship W4302287398A5012710359 @default.
- W4302287398 hasAuthorship W4302287398A5015829148 @default.
- W4302287398 hasAuthorship W4302287398A5019993467 @default.
- W4302287398 hasAuthorship W4302287398A5036665064 @default.
- W4302287398 hasAuthorship W4302287398A5037962146 @default.
- W4302287398 hasAuthorship W4302287398A5052806409 @default.
- W4302287398 hasAuthorship W4302287398A5057207523 @default.
- W4302287398 hasAuthorship W4302287398A5060595885 @default.
- W4302287398 hasAuthorship W4302287398A5070737798 @default.
- W4302287398 hasBestOaLocation W43022873981 @default.
- W4302287398 hasConcept C111113717 @default.
- W4302287398 hasConcept C112705442 @default.
- W4302287398 hasConcept C126322002 @default.
- W4302287398 hasConcept C150903083 @default.
- W4302287398 hasConcept C207001950 @default.
- W4302287398 hasConcept C26291073 @default.
- W4302287398 hasConcept C2777628954 @default.
- W4302287398 hasConcept C2778837598 @default.
- W4302287398 hasConcept C2781024287 @default.
- W4302287398 hasConcept C2781080829 @default.